vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and LifeMD, Inc. (LFMD). Click either name above to swap in a different company.
CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $60.2M, roughly 1.1× LifeMD, Inc.). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -6.3%, a 40.3% gap on every dollar of revenue. Over the past eight quarters, LifeMD, Inc.'s revenue compounded faster (24.8% CAGR vs 22.6%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
CAC vs LFMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $64.3M | $60.2M |
| Net Profit | $21.9M | $-3.8M |
| Gross Margin | — | 87.7% |
| Operating Margin | — | -3.3% |
| Net Margin | 34.0% | -6.3% |
| Revenue YoY | — | 13.0% |
| Net Profit YoY | — | 18.3% |
| EPS (diluted) | $1.29 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | — | ||
| Q3 25 | $65.4M | $60.2M | ||
| Q2 25 | $62.3M | $62.7M | ||
| Q1 25 | $60.1M | $64.1M | ||
| Q4 24 | $47.6M | — | ||
| Q3 24 | $45.0M | $53.3M | ||
| Q2 24 | $42.8M | $50.7M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | — | ||
| Q3 25 | $21.2M | $-3.8M | ||
| Q2 25 | $14.1M | $-1.6M | ||
| Q1 25 | $7.3M | $-183.8K | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $13.1M | $-4.7M | ||
| Q2 24 | $12.0M | $-6.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 87.7% | ||
| Q2 25 | — | 88.1% | ||
| Q1 25 | — | 86.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 90.1% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | — | ||
| Q3 25 | 40.5% | -3.3% | ||
| Q2 25 | 28.5% | -0.7% | ||
| Q1 25 | 10.3% | 1.5% | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 35.2% | -7.5% | ||
| Q2 24 | 34.7% | -12.4% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | — | ||
| Q3 25 | 32.4% | -6.3% | ||
| Q2 25 | 22.6% | -2.6% | ||
| Q1 25 | 12.2% | -0.3% | ||
| Q4 24 | 30.8% | — | ||
| Q3 24 | 29.1% | -8.7% | ||
| Q2 24 | 28.0% | -13.6% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | — | ||
| Q3 25 | $1.25 | — | ||
| Q2 25 | $0.83 | $-0.05 | ||
| Q1 25 | $0.43 | $-0.02 | ||
| Q4 24 | $1.00 | — | ||
| Q3 24 | $0.90 | $-0.13 | ||
| Q2 24 | $0.81 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $514.4M | — |
| Stockholders' EquityBook value | $710.0M | $1.3M |
| Total Assets | $7.0B | $66.0M |
| Debt / EquityLower = less leverage | 0.72× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $36.2M | ||
| Q1 25 | — | $34.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $37.6M | ||
| Q2 24 | — | $35.7M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $15.9M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | — | ||
| Q3 25 | $676.4M | $1.3M | ||
| Q2 25 | $652.1M | $-1.8M | ||
| Q1 25 | $640.1M | $-2.3M | ||
| Q4 24 | $531.2M | — | ||
| Q3 24 | $529.9M | $-7.7M | ||
| Q2 24 | $508.3M | $-4.2M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | — | ||
| Q3 25 | $7.0B | $66.0M | ||
| Q2 25 | $6.9B | $73.6M | ||
| Q1 25 | $7.0B | $73.6M | ||
| Q4 24 | $5.8B | — | ||
| Q3 24 | $5.7B | $72.6M | ||
| Q2 24 | $5.7B | $63.8M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $-147.1K |
| Free Cash FlowOCF − Capex | — | $-944.4K |
| FCF MarginFCF / Revenue | — | -1.6% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $16.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | — | ||
| Q3 25 | $36.1M | $-147.1K | ||
| Q2 25 | $6.0M | $8.6M | ||
| Q1 25 | $1.0M | $3.1M | ||
| Q4 24 | $60.9M | — | ||
| Q3 24 | $-14.5M | $6.7M | ||
| Q2 24 | $14.5M | $4.5M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | — | ||
| Q3 25 | $35.4M | $-944.4K | ||
| Q2 25 | $4.5M | $7.8M | ||
| Q1 25 | $-727.0K | $2.9M | ||
| Q4 24 | $55.4M | — | ||
| Q3 24 | $-16.2M | $6.3M | ||
| Q2 24 | $13.2M | $3.9M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | — | ||
| Q3 25 | 54.1% | -1.6% | ||
| Q2 25 | 7.3% | 12.5% | ||
| Q1 25 | -1.2% | 4.6% | ||
| Q4 24 | 116.4% | — | ||
| Q3 24 | -36.0% | 11.7% | ||
| Q2 24 | 30.8% | 7.7% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | — | ||
| Q3 25 | 1.1% | 1.3% | ||
| Q2 25 | 2.4% | 1.3% | ||
| Q1 25 | 2.9% | 0.2% | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 3.8% | 0.8% | ||
| Q2 24 | 3.0% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
LFMD
| Telehealth Subscription Revenue | $27.3M | 45% |
| Telehealth | $20.0M | 33% |
| Work Simpli Revenue | $12.9M | 21% |
| Product And Services | $2.5M | 4% |